Qualification
2548
Pediatric Hematology and Oncology
Children’s Hospital of Michigan
Ann Arbor, MI, USA
2545
อ.ว. กุมารเวชศาสตร์โลหิตวิทยา แพทยสภา
จุฬาลงกรณ์มหาวิทยาลัย
ประเทศไทย
2543
อ.ว. กุมารเวชศาสตร์ แพทยสภา
จุฬาลงกรณ์มหาวิทยาลัย
ประเทศไทย
2539
แพทยศาสตร์บัณฑิต
มหาวิทยาลัยสงขลานครินทร์
ประเทศไทย
Selected Publications
2024
Poparn, H., Kittikalayawong, Y., Techavichit, P., Lauhasurayotin, S., Chiengthong, K., Chaweephisal, P., & Sosothikul, D. (2024). The Incidence and Methods for Detecting Aspirin Resistance in Pediatric Patients. Pediatric health, medicine and therapeutics, 15, 333–338. https://doi.org/10.2147/PHMT.S478540
2024
Srichumpuang, C., Rakmanotham, A., Moonla, C., & Sosothikul, D. (2024). Moderate- to vigorous-intensity physical activities for hemophilia A patients during low-dose pharmacokinetic-guided extended half-life factor VIII prophylaxis. Orphanet journal of rare diseases, 19(1), 135. https://doi.org/10.1186/s13023-024-03092-2
2025
Kessakorn, N., Gosriwatana, I., Sasipong, N., Srichumpuang, C., Moonla, C., & Sosothikul, D. (2025). Low-Dose Emicizumab Versus Low-/Intermediate-Dose Factor VIII Secondary Prophylaxis for Noninhibitor Haemophilia A Patients With Severe Bleeding Phenotype. Haemophilia : the official journal of the World Federation of Hemophilia, 31(1), 122–131. https://doi.org/10.1111/hae.15146
2024
Trirut, C., Sosothikul, D., Ittiwut, R., Ittiwut, C., Pongsewalak, S., Songthawee, N., Natesirinilkul, R., Banjerdlak, P., Na Songkhla, P., Komvilaisak, P., Moonla, C., & Suphapeetiporn, K. (2024). F8 variants and their genotype-phenotype correlations in Thai patients with haemophilia A: a nationwide multicentre study. Journal of clinical pathology, jcp-2024-209542. Advance online publication. https://doi.org/10.1136/jcp-2024-209542
2024
Tongruang, C., Wananukul, S., Chatproedprai, S., Narkbunnam, N., Nitiyarom, R., Sirachainan, N., Natesirinilkul, R., Chaweephisal, P., & Sosothikul, D. (2024). Cost and effectiveness comparison of sirolimus versus standard treatment in Kasabach-Merritt phenomenon: a real-world evidence study in Thailand. Pediatric hematology and oncology, 41(3), 229–239. https://doi.org/10.1080/08880018.2023.2300485
2024
Youthong, P., Pakakasama, S., Komvilaisak, P., Rujkijyanont, P., Choed-Amphai, C., Phuakpet, K., Moonla, C., Polprasert, C., & Sosothikul, D. (2024). Characteristics and therapeutic outcomes of subcutaneous panniculitis-like T-cell lymphoma with and without germline HAVCR2 mutations in Thai children and adolescents. Orphanet journal of rare diseases, 19(1), 426. https://doi.org/10.1186/s13023-024-03438-w
2024
Lauhasurayotin, S., Moonla, C., Ittiwut, R., Ittiwut, C., Songthawee, N., Komvilaisak, P., Natesirinilkul, R., Sirachainan, N., Rojnuckarin, P., Sosothikul, D., & Suphapeetiporn, K. (2024). Genetic variations of type 2 and type 3 von Willebrand diseases in Thailand. Journal of clinical pathology, 78(1), 57–63. https://doi.org/10.1136/jcp-2023-209123
2023
Rakmanotham, A., Moonla, C., & Sosothikul, D. (2023). Clinical outcomes of low-dose pharmacokinetic-guided extended half-life versus low-dose standard half-life factor VIII concentrate prophylaxis in haemophilia A patients. Haemophilia : the official journal of the World Federation of Hemophilia, 29(1), 156–164. https://doi.org/10.1111/hae.14700
2022
Poparn, H., Srichumpuang, C., Sosothikul, D., Jantarabenjakul, W., Lauhasurayotin, S., Techavichit, P., Chiangthong, K., & Poovorawan, Y. (2022). Immune Response after 2 Doses of BNT162b2 mRNA COVID-19 Vaccinations in Children and Adolescents with Cancer and Hematologic Diseases. Asian Pacific journal of cancer prevention : APJCP, 23(6), 2049–2055. https://doi.org/10.31557/APJCP.2022.23.6.2049
2021
Chaweephisal, P., Sosothikul, D., Polprasert, C., Wananukul, S., & Seksarn, P. (2021). Subcutaneous Panniculitis-like T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis Syndrome in Children and Its Essential Role of HAVCR2 Gene Mutation Analysis. Journal of pediatric hematology/oncology, 43(1), e80–e84. https://doi.org/10.1097/MPH.0000000000001954
